SELLAS Life Sciences (SLS) Short term Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 6 years of Short term Debt data on file, last reported at $76000.0 in Q3 2018.

• Short term Debt for Q3 2018 came in at $76000.0, down 99.38% year-over-year; the trailing twelve-month figure through Sep 2018 was $76000.0 (down 99.38% YoY), and the FY2017 annual result was $8.4 million, up 390.17% from the prior year.
• Short term Debt retreated to $76000.0 in Q3 2018 per SLS's latest filing, from $7.8 million in the prior quarter.
• Over five years, Short term Debt peaked at $23.7 million in Q3 2016 and troughed at $76000.0 in Q3 2018.
• A 5-year average of $7.7 million and a median of $4.2 million in 2015 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2014 and 2018: Short term Debt jumped 1254.15% in 2014, then tumbled 99.38% in 2018.
• A 5-year view of Short term Debt shows it stood at $3.9 million in 2014, then grew by 21.2% to $4.7 million in 2015, then tumbled by 63.94% to $1.7 million in 2016, then jumped by 390.17% to $8.4 million in 2017, then slumped by 99.09% to $76000.0 in 2018.
• Business Quant data shows SLS's Short term Debt at $76000.0 in Q3 2018, $7.8 million in Q2 2018, and $8.5 million in Q1 2018.